Form 4: Hims & Hers COO Earns 365K Performance-Based Shares

Hims & Hers Health, Inc.'s Chief Operating Officer, Michael Chi, earned 365,058 performance-based restricted stock units, reflecting met performance criteria.

Summary

• Michael Chi, Chief Operating Officer of Hims & Hers Health, Inc., earned 365,058 performance-based restricted stock units (PRSUs).
• Each PRSU represents a contingent right to receive one share of the Company's Class A common stock.
• The Compensation Committee of the Company's Board of Directors certified that the performance criteria for this award were met as of February 23, 2026.
• The shares underlying these PRSUs will be delivered to Mr. Chi on or about March 15, 2026.
• Following this transaction, Mr. Chi beneficially owns 670,219 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive indicator, as it confirms the achievement of performance targets and strengthens executive alignment with shareholder interests, though it's a routine compensation event.

Positives

• The Compensation Committee certified that performance criteria for the PRSUs were met, indicating successful achievement of company goals.
• The award of 365,058 shares to a key executive aligns management's interests with shareholder value.

Future Outlook

The shares underlying the PRSUs are expected to be delivered to Michael Chi on or about March 15, 2026.

Management Comments

• The Compensation Committee of the Company's Board of Directors certified that the performance criteria established in connection with this award has been met as of February 23, 2026.

Industry Context

StockSavvy.ai notes that executive compensation tied to performance-based restricted stock units is a common practice in the healthcare and technology sectors, aiming to incentivize long-term executive performance and align management interests with shareholder returns. This type of award is typical for growth-oriented companies like Hims & Hers.

Comparison to Industry Standards

• This type of performance-based equity award is standard practice across many publicly traded companies, particularly in the high-growth tech and healthcare sectors.
• Companies like Teladoc Health (TDOC) and GoodRx (GDRX) also utilize similar long-term incentive plans to retain and motivate key executives, linking compensation directly to company performance metrics.
• The size of the award for a COO is generally commensurate with the company's market capitalization and the executive's role in achieving strategic objectives.

Corporate Governance

Related Party Transactions

• The award of 365,058 performance-based restricted stock units to Michael Chi, the Chief Operating Officer, constitutes a related party transaction as it involves compensation to an executive.

Stakeholder Impact

• Shareholders: Positive, as it indicates performance criteria were met and aligns executive incentives with long-term company success.
• Employees: May signal positive company performance and a stable leadership team.

Next Steps

• Delivery of 365,058 shares of Class A common stock to Michael Chi on or about March 15, 2026.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event where performance-based restricted stock units were earned due to met performance criteria. While positive as it indicates company performance and executive alignment, it does not present new fundamental information that would warrant a change in investment thesis. It's a standard disclosure for a well-performing executive.

Keywords

Hims & Hers Health, HIMS, Michael Chi, Chief Operating Officer, COO, Performance-Based Restricted Stock Units, PRSUs, Stock Award, Insider Ownership, Executive Compensation, SEC Form 4